Concentrated potassium chloride infusions in critically ill patients with hypokalemia

J Clin Pharmacol. 1994 Nov;34(11):1077-82. doi: 10.1002/j.1552-4604.1994.tb01984.x.

Abstract

Although concentrated infusions of potassium chloride commonly are used to treat hypokalemia in intensive care unit patients, few studies have examined their effects on plasma potassium levels. Forty patients with hypokalemia were given infusions of 20 mmol of potassium chloride in 100 mL of normal saline over 1 hour; 26 patients received the infusions through the central vein and 14 patients through the peripheral vein. Plasma potassium ([K]p) was measured at 15-minute intervals during and after the infusion in 31 patients. delta K was defined as the difference between each potassium determination and baseline plasma potassium concentration. Continuous electrocardiographic recording was carried out during the infusion and during the 1-hour period immediately preceding the infusion. Mean baseline [K]p was 2.9 mmol/L and all subsequent plasma concentrations significantly increased from baseline. Mean peak [K]p was 3.5 mmol/L, [K]p (1 hour postinfusion) was 3.2 mmol/L, and mean postinfusion delta K was 0.48 mmol/L (range -0.1-1.7 mmol/L). Arrhythmias, changes in cardiac conduction intervals, and other complications did not occur. The frequency of premature ventricular beats decreased significantly during the infusion compared with that of the control period. The high concentration (200 mmol/L) and rate of delivery (20 mmol/hr) of the potassium chloride infusions were well tolerated, decreased the frequency of ventricular arrhythmias, and did not cause transient hyperkalemia.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Critical Illness
  • Electrocardiography
  • Female
  • Humans
  • Hypokalemia / drug therapy*
  • Hypokalemia / physiopathology
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Potassium Chloride / therapeutic use*
  • Prospective Studies

Substances

  • Potassium Chloride